The use of IFN-α in cancer therapy, has taught us that systemic IFN levels lead to sickness behavioural responses and it has been shown that systemic injection of interferons can induce interferon-responsive genes in the hypothalamus (Wang et al., 2008). This evidence concerns the gene IFNA1 and cancer.